Session date: 
04/09/2020 - 12:15pm to 1:15pm

J. Michael Bostwick, M.D.

Learning Objectives:

  • Recognize similarities and differences between how marijuana, hemp, and CBD are treated in federal law
  • Explore how the dearth of manufacturing standards results in CBD products of uncertain composition and purity
  • Describe characteristics of relatively safe CBD products if you wish to recommend them to patients


Financial Disclosures - None
Off-label and/or Investigational Use Disclosure - None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010image within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

Presenter: 
J. Michael Bostwick, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota